Europe Neurosurgical Robotics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Component [Equipment/System (Robot Machines, Navigation System, Planner & Simulators, and Others), Accessories, and Services], Application [Spinal (Laminectomy, Discectomy, Spinal Fusion, Disc Replacement, Foraminotomy, and Others) and Cranial (Craniotomy, Brain Biopsy, Thermal ablation of Seizure and Others)], Surgery Type (Minimally Invasive and Open Surgery), and End User (Hospitals, Specialty Clinics, and Others)
The neurosurgical robotics market in Europe is expected to grow from US$ 457.51 million in 2022 to US$ 1,101.85 million by 2028. It is estimated to grow at a CAGR of 15.8% from 2022 to 2028.
Advantages of Neurosurgical Robots Encourage Key Players to Develop Innovative Products
Brain and spinal surgeries require a high degree of technical proficiency, and robotic systems may play a crucial role in achieving desired outcomes. Over the traditional neurosurgeries, neurosurgical robots possess several advantages, including increased accuracy, better outcomes, sooner recovery, and shorter hospital stay. Minimally invasive robotic neurosurgery or robotic neurological minimally invasive surgery (RNMIS) represents a preferred option for the medical centers, surgeons, and patients. The use of robotics in neurosurgery eliminates mechanical errors, reduces operating duration, and provides the same or greater margins with minimal-access surgery. For instance, Renaissance Guidance System is a spine surgical robot developed by Mazor Robotics. The system helps improve accuracy and minimizes recovery time. It allows surgeons to pre-plan surgery in a 3D field and guides them during surgery. The computer guidance allows superior accuracy, particularly if a patient’s anatomy shifts during surgery.
Moreover, owing to the increased advancements in neurosurgery, key players are working to grab a significant share in the neurosurgical robotics market. According to the data published by The Spine Market Group, Johnson & Johnson has around 16% of the spine market. Also, according to Johnson & Johnson CEO, the company is working to unlock the full potential and benefits of robotic and digital technologies. The growing demand for minimally invasive surgeries fueled the neurosurgical robotics market. In March 2019, Zimmer Biomet received FDA clearance of ROSA ONE Spine System for robotic-assisted surgeries. ROSA ONE Spine is a robotic and surgical navigation system designed to aid surgeons in performing thoracolumbar minimally invasive and complex spine procedures. Additionally, the approval of ROSA ONE Spine System strengthened the company's comprehensive ROSA ONE Brain Robotic system.
Furthermore, the growing adoption of robotic neurosurgeries help efficiently execute complicated tasks that require a high degree of accuracy. The robots assist surgeons in preoperative planning and executing the tasks during surgery with a high degree of dexterity. For instance, Remebot neurosurgical robot integrates image processing and surgical planning, automatic positioning and navigation, and a multifunctional surgical operation platform. It assists doctors in completing nearly 100 operations in 12 categories with minimal invasiveness, precision, and efficiency. Thus, the broad range of advantages and applications of neurosurgical robots propel the Europe neurosurgical robotics market.
The European neurosurgical robotics market is divided into Germany, the UK, France, Italy, and Spain. Countries such as Germany and the UK are expected to be the largest contributor to the neurosurgical robotics market due to the introduction and rapid adoption of technologically advanced products, growing product approvals, and rising government initiatives & funding. The rest of Europe consists of countries such as Poland, Austria, Switzerland, Sweden, Norway, Denmark, Belgium, and the Netherlands. The increasing number of surgical procedures leading to the demand for neurosurgical robotics are likely to pose significant growth opportunities for the market. Also, the growing number of hospitals using new technologically advanced facilities in the region is likely to fuel the growth of the market during the forecast period. Economic prosperity, population growth, hospitals expanding the number of operating rooms, along with increased attention to physical health and improved insurance coverage are some of the key factors expected to drive a moderate growth of the neurosurgical robotics market in the rest of Europe during the forecast period.
Europe Neurosurgical Robotics Market Revenue and Forecast to 2028 (US$ Million)
Europe Neurosurgical Robotics Market Segmentation
The Europe neurosurgical robotics market is segmented into component, application, surgery type, end user, and country.
Based on component type, the Europe neurosurgical robotics market is segmented into equipment/system, accessories, and services. The equipment/system segment is further segmented into robot machines, navigation system, planner & simulators, and others. The accessories segment is anticipated to hold the largest share of the market in 2022. The Europe neurosurgical robotics market, based on application, is segmented into spinal and cranial. Spinal application is further segmented into spinal fusion, laminectomy, disc replacement, discectomy, foraminotomy, and others. The cranial segment is also subsegmented into brain biopsy, thermal ablation of seizure, surgical treatment of movement disorders, and others. In 2022, the spinal segment is likely to hold the largest share of the market, by application.
The Europe neurosurgical robotics market, based on surgery type, is segmented into open and minimally invasive. In 2022, the minimally invasive segment is anticipated to hold a larger share of the market.
Based on end user, the Europe neurosurgical robotics market is segmented into hospitals, specialty centers, and others. In 2022, the hospitals segment is anticipated to hold the largest share of the market. Based on country, the market is segmented into Germany, France, Italy, UK, Spain, and the Rest of Europe. The Rest of Europe is anticipated to dominate the market in 2022. Accuray Incorporated; B. Braun Melsungen AG; Brainlab AG; Globus Medical, Inc.; Medtronic; Renishaw plc; and Zimmer Biomet are among the leading companies operating in the neurosurgical robotics market in the region.
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe neurosurgical robotics market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe neurosurgical robotics market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the neurosurgical robotics market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook